{"id":332,"date":"2019-05-20T23:21:20","date_gmt":"2019-05-20T23:21:20","guid":{"rendered":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?post_type=press-release&p=332"},"modified":"2024-05-07T19:17:13","modified_gmt":"2024-05-07T19:17:13","slug":"barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019","status":"publish","type":"press-release","link":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/","title":{"rendered":"Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019"},"content":{"rendered":"

Bio\u20acquity 2019, the most important biopharmaceutical investor conference in Europe, took place in Barcelona for the first time on May 20-21, 2019. Organized by BioCentury and EBD Group is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio\u20acquity Europe has showcased more than 800 leading European companies to thousands of investment and pharma business development professionals.<\/p>\n

On May 21 from 1:15pm to 2:45pm, a selection of companies and projects in the pre-seed phase presented in front of a panel of investing judges in two parallel sessions “Pre-seed Showcase”. 12 companies and Catalan projects participated, Ona Therapeutics among them.<\/p>\n

See more information here:<\/p>\n

https:\/\/www.biocat.cat\/en\/what-we-do\/acceleration-and-innovation\/fairs-and-congresses\/bioequity-2019<\/a><\/p>\n

https:\/\/www.biocentury.com\/conferences\/bioequity-europe-2019<\/a><\/p>\n","protected":false},"template":"","class_list":["post-332","press-release","type-press-release","status-publish","hentry"],"acf":[],"yoast_head":"\nOna Therapeutics | Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ona Therapeutics | Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019\" \/>\n<meta property=\"og:description\" content=\"Bio\u20acquity 2019, the most important biopharmaceutical investor conference in Europe, took place in Barcelona for the first time on May 20-21, 2019. Organized by BioCentury and EBD Group is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Ona Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-07T19:17:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"968\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@onatherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\\\/\",\"name\":\"Ona Therapeutics | Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\"},\"datePublished\":\"2019-05-20T23:21:20+00:00\",\"dateModified\":\"2024-05-07T19:17:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"name\":\"Ona Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\",\"name\":\"Ona Therapeutics\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"width\":968,\"height\":440,\"caption\":\"Ona Therapeutics\"},\"image\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/onatherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ona-therapeutics\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ona Therapeutics | Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/","og_locale":"en_US","og_type":"article","og_title":"Ona Therapeutics | Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019","og_description":"Bio\u20acquity 2019, the most important biopharmaceutical investor conference in Europe, took place in Barcelona for the first time on May 20-21, 2019. Organized by BioCentury and EBD Group is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top […]","og_url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/","og_site_name":"Ona Therapeutics","article_modified_time":"2024-05-07T19:17:13+00:00","og_image":[{"width":968,"height":440,"url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@onatherapeutics","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/","name":"Ona Therapeutics | Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019","isPartOf":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website"},"datePublished":"2019-05-20T23:21:20+00:00","dateModified":"2024-05-07T19:17:13+00:00","breadcrumb":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/barcelona-spain-ona-therapeutics-pitches-at-bioequity-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/"},{"@type":"ListItem","position":2,"name":"Barcelona, Spain. ONA Therapeutics pitches at BioEquity 2019"}]},{"@type":"WebSite","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","name":"Ona Therapeutics","description":"","publisher":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization","name":"Ona Therapeutics","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","contentUrl":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","width":968,"height":440,"caption":"Ona Therapeutics"},"image":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/onatherapeutics","https:\/\/www.linkedin.com\/company\/ona-therapeutics\/"]}]}},"_links":{"self":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release\/332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/types\/press-release"}],"wp:attachment":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/media?parent=332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}